In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitorNATURE BIOMEDICAL ENGINEERINGIF26.62024-12-050PRE
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoireMOLECULAR THERAPYIF122022-01-0110OA
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trialLANCET INFECTIOUS DISEASESIF312021-10-0160OAAI
A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020MOLECULAR THERAPY-NUCLEIC ACIDSIF02021-06-0125OAAI
A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivoNATURE BIOTECHNOLOGYIF41.72019-12-2368OAAI
Cpf1 proteins excise CRISPR RNAs from mRNA transcripts in mammalian cellsNATURE CHEMICAL BIOLOGYIF13.72017-06-1958OAAI
Suppression of mRNAs Encoding Tegument Tetraspanins from Schistosoma mansoni Results in Impaired Tegument TurnoverPLOS PATHOGENSIF4.92010-04-1596OAAI
Transcriptional Changes in Schistosoma mansoni during Early Schistosomula Development and in the Presence of ErythrocytesPLOS NEGLECTED TROPICAL DISEASESIF3.42010-02-0970OAAI
Schistosome membrane proteins as vaccines血吸虫膜蛋白作为疫苗INTERNATIONAL JOURNAL FOR PARASITOLOGYIF3.22007-03-01139PREAI
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasisNATURE MEDICINEIF502006-06-18347PREAI
Transcriptome profiling of lung schistosomula, in vitro cultured schistosomula and adult Schistosoma japonicumCELLULAR AND MOLECULAR LIFE SCIENCESIF6.22006-03-2970OA
MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cellsJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92001-05-01297OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向